Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence KMADEAGSEADHEGTHSTKRGHAKSRPV
Primary information
sequence IDSeq_4281
Peptide sequenceKMADEAGSEADHEGTHSTKRGHAKSRPV
CancerPDF_ID CancerPDF_ID8529, CancerPDF_ID9708, CancerPDF_ID12727,
PMID23667664,21533267,27058005
Protein NameFibrinogen alpha,Fibrinogen alpha chain,Fibrinogen alpha chain
UniprotKB Entry NameFIBA_HUMAN,FIBA_HUMAN,FIBA_HUMAN
FluidSerum,Serum,Serum
M/Z2988.42,748.1,3005.608
Charge1,4,NA
Mass (in Da)2991.23,NA,NA
fdrNA,NA,NA
Profiling TechniqueMALDI-TOF,LC-MS,MALDI-TOF
Peptide Identification techniqueFT-ICR MS/MS + nano-HPLC,LC/MS/MS,LC-MS/MS
Quantification TechniqueNA,Multiple Reaction Monitoring,NA
Labelled/Label FreeLabel Free,Label Free,Label Free
FDRNA,1.49,NA
CancerPDF_ID CancerPDF_ID8529, CancerPDF_ID9708, CancerPDF_ID12727,
p-ValueNA,NA,"0.096,less than 0.05,0.059"
SoftwareMASCOT,MASCOT,Proteome Discoverer
Length28,28,28
Cancer Type"Breast cancer, Lung cancer, Rectal cancer",Lung adenocarcinoma,Breast cancer
DatabaseNA,Swissprot Database (57.4),SwissProt Database
ModificationNA,NA,Oxidation (M)
Number of Patients"Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",62 lung adenocarcinoma and 30 healthy control," 28 were diagnosed with Breast cancer, 27 remained cancer-free with BRCA carrier. Of the remaining patients, 39 were diagnosed with sporadic breast cancer (SBC), and 38 were healthy volunteers (WT)."
RegulationNA,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal","Upregulated with the fold change of 1.73 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 2.39, Upregulated in BC vs healthy with 2.324 fold change"
ValidationNA,MRM-based validation of 19 candidates,NA
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasNA
IEDB